BRPI0515618A - cepa de lactobacillus plantarum, composição para produzir cla, processo para produção em massa de cla alimento funcional redutor de corpos de gordura, produtos diários, alimentos fermentados, medicamento para prevenção e tratamento de doenças relacionadas com a obesidade - Google Patents

cepa de lactobacillus plantarum, composição para produzir cla, processo para produção em massa de cla alimento funcional redutor de corpos de gordura, produtos diários, alimentos fermentados, medicamento para prevenção e tratamento de doenças relacionadas com a obesidade

Info

Publication number
BRPI0515618A
BRPI0515618A BRPI0515618-1A BRPI0515618A BRPI0515618A BR PI0515618 A BRPI0515618 A BR PI0515618A BR PI0515618 A BRPI0515618 A BR PI0515618A BR PI0515618 A BRPI0515618 A BR PI0515618A
Authority
BR
Brazil
Prior art keywords
cla
strain
lactobacillus plantarum
fat
mass production
Prior art date
Application number
BRPI0515618-1A
Other languages
English (en)
Inventor
Yeon-Hee Lee
Kyung-Soo Paek
Kenny Sohn
Tae-Jin Kim
Jee-Hoon Koh
Bum-Suk Park
Original Assignee
Pl Bio Co Ltd
Cj Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pl Bio Co Ltd, Cj Corp filed Critical Pl Bio Co Ltd
Publication of BRPI0515618A publication Critical patent/BRPI0515618A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/20—Products from fruits or vegetables; Preparation or treatment thereof by pickling, e.g. sauerkraut or pickles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6431—Linoleic acids [18:2[n-6]]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

CEPA DE LACTOBACILLUS PLANTARUM, COMPOSIçãO PARA PRODUZIR CLA, PROCESSO PARA PRODUçãO EM MASSA DE CLA ALIMENTO FUNCIONAL REDUTOR DE CORPOS DE GORDURA, PRODUTOS DIáRIOS, ALIMENTOS FERMENTADOS, MEDICANENTO PARA PREVENçãO E TRATAMENTO DE DOENçAS RELACIONADAS COM A OBESIDADE. A presente invenção refere-se a uma cepa de Lactobacillus com uma atividade redutora de corpos de gordura e a provisão de uma cepa de Lactobacillus plantarum PL62 KCCM-10655P. A cepa da invenção pode ser diretamente utilizada como alimentos funcionais redutores de corpos de gordura, ou pode ser utilizada como aditivos de alimentos funcionados redutores de corpo-de-gordura. Os materiais inibidores de corpos-de-gordura que a cepa da presente invenção produz podem ser isolados para serem utilizados. Adicionalmente, no caso em que alimentos fermentados são produzidos usando a cepa da invenção, são providas condições capazes de ter um efeito redutor máximo nos corpos-de-gordura.
BRPI0515618-1A 2004-09-02 2005-06-30 cepa de lactobacillus plantarum, composição para produzir cla, processo para produção em massa de cla alimento funcional redutor de corpos de gordura, produtos diários, alimentos fermentados, medicamento para prevenção e tratamento de doenças relacionadas com a obesidade BRPI0515618A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020040070132A KR100686558B1 (ko) 2004-09-02 2004-09-02 체지방 저하 기능성 락토바실러스 플랜타륨와 이를 함유한 식품
PCT/KR2005/002067 WO2006025643A1 (en) 2004-09-02 2005-06-30 Lactobacillus plantarum with body-fat reducing activity and the foods containing them

Publications (1)

Publication Number Publication Date
BRPI0515618A true BRPI0515618A (pt) 2008-07-15

Family

ID=36000264

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515618-1A BRPI0515618A (pt) 2004-09-02 2005-06-30 cepa de lactobacillus plantarum, composição para produzir cla, processo para produção em massa de cla alimento funcional redutor de corpos de gordura, produtos diários, alimentos fermentados, medicamento para prevenção e tratamento de doenças relacionadas com a obesidade

Country Status (9)

Country Link
US (1) US20080057044A1 (pt)
EP (1) EP1791946A4 (pt)
JP (1) JP2008511312A (pt)
KR (1) KR100686558B1 (pt)
CN (1) CN101044234A (pt)
BR (1) BRPI0515618A (pt)
CA (1) CA2579022C (pt)
MX (1) MX2007002528A (pt)
WO (1) WO2006025643A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5025930B2 (ja) * 2005-09-13 2012-09-12 株式会社桃屋 ラクトバチルス・プランタラムの菌体を有効成分とする体脂肪率低減剤
JP5036020B2 (ja) * 2005-11-30 2012-09-26 雪印メグミルク株式会社 腎周囲脂肪蓄積抑制剤
PL1981516T3 (pl) * 2006-01-27 2019-03-29 Dupont Nutrition Biosciences Aps Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
AU2007292786B2 (en) * 2006-09-04 2013-02-14 Megmilk Snow Brand Co., Ltd. Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor
WO2008075949A1 (en) * 2006-12-20 2008-06-26 Friesland Brands B.V. Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms
JP5201832B2 (ja) * 2006-12-25 2013-06-05 花王株式会社 脂肪分解促進用皮膚外用剤
JP2008214253A (ja) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 内臓脂肪減少剤
JPWO2008120712A1 (ja) * 2007-03-30 2010-07-15 サントリーホールディングス株式会社 交感神経活動亢進作用を有する医薬組成物又は飲食物
EP2192909A2 (en) * 2007-10-01 2010-06-09 University College Cork-National University of Ireland, Cork Modulation of tissue fatty acid composition of a host by human gut bacteria
KR101010914B1 (ko) * 2008-04-28 2011-01-26 주식회사 엔유씨전자 항비만 및 뇌기능개선 관련 생리활성 기능을 가지는 프로바이오틱 유산균 락토바실러스 플란타늄
KR101068524B1 (ko) * 2008-07-07 2011-09-30 한국식품연구원 락토바실러스 프란타럼 μ23 균주를 포함하는 발효유 및이의 제조방법
CN101748083B (zh) * 2008-12-11 2012-01-04 吉林省农业科学院 植物乳杆菌发酵剂及其制备方法与专用菌株
KR100996577B1 (ko) 2009-04-01 2010-11-24 주식회사한국야쿠르트 혈중 콜레스테롤 강하와 비만 억제 효능을 갖는 신규의 락토바실러스 커베터스 에이취와이7601 및 이를 유효성분으로 함유하는 제품
US20120034199A1 (en) 2009-04-09 2012-02-09 Teck Chwen Loh Monogastric animal feed
EP2311473A1 (en) * 2009-10-09 2011-04-20 AB-Biotics Producciones Industriales De Microbiotas, S.L. Lactobacillus plantarum strains as probiotics
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
JP5076029B2 (ja) * 2010-07-30 2012-11-21 株式会社明治 メタボリックシンドローム改善効果を有する乳酸菌
JPWO2013168310A1 (ja) 2012-05-10 2015-12-24 国立大学法人京都大学 オキソ脂肪酸及び希少脂肪酸の製造法
KR101580732B1 (ko) * 2013-01-31 2015-12-28 부산대학교 산학협력단 신규한 스타터 균주 및 이를 이용한 김치를 포함하는 기능성 발효식품의 제조방법
KR101566989B1 (ko) 2014-09-03 2015-11-06 조선대학교산학협력단 김치로부터 분리된 콜레스테롤 저하능을 갖는 유산균 및 그의 용도
CN104388482B (zh) * 2014-10-28 2017-07-11 南昌大学 一种利用静息乳酸菌技术转化菜油脚料生产共轭亚油酸的方法
KR102125548B1 (ko) 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
CN109549195A (zh) * 2017-09-27 2019-04-02 家宝农产 具有抗肥胖活性的含有发酵香橙渣的食物成分
TWI636134B (zh) * 2017-10-20 2018-09-21 葡萄王生技股份有限公司 一種胚芽乳酸桿菌、組合物、培養方法及降血脂及／或降低肝功能指數的用途
JP2018154649A (ja) * 2018-06-08 2018-10-04 株式会社東洋新薬 コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物
TWI824127B (zh) * 2018-12-11 2023-12-01 生合生物科技股份有限公司 胚芽乳酸桿菌ｔｗｋ１０用於製備降體脂醫藥組合物之用途
CN111676157A (zh) * 2020-06-05 2020-09-18 杭州娃哈哈科技有限公司 一种基于植物乳杆菌的组合物及其制备方法
CN111714572B (zh) * 2020-06-08 2024-02-09 杭州娃哈哈科技有限公司 一种基于植物乳杆菌的益生菌片剂及其制备方法
KR102198827B1 (ko) * 2020-07-24 2021-01-05 주식회사 리부트라이프 신규 락토바실러스 플란타럼 균주 및 이를 포함하는 비만 예방 또는 치료용 조성물
HU231571B1 (hu) * 2021-06-04 2024-12-28 ZYMBIOSYS Kutató és Fejlesztő Korlátolt Felelősségű Társaság 50% Lactiplantibacillus Plantarum SNI3 mikroorganizmus törzs
KR102696606B1 (ko) * 2021-12-06 2024-08-21 국립부경대학교 산학협력단 항콜레스테롤 활성을 갖는 신규 락토바실러스 플란타룸 bj21 균주 및 이의 용도
CN119343145A (zh) * 2022-05-25 2025-01-21 全南大学校产学协力团 包含植物乳杆菌nchbl-004菌株或其培养液的代谢性疾病预防、治疗或改善用组合物
KR102512998B1 (ko) * 2022-08-29 2023-03-23 콜마비앤에이치 주식회사 체지방 감소용 신규 유산균 락티플랜티바실러스 플란타룸 sko-001 및 이의 용도
CN115960767B (zh) * 2022-11-09 2024-04-26 厦门元之道生物科技有限公司 一种植物乳植杆菌及其应用
CN115943994B (zh) * 2022-12-14 2025-02-14 南昌大学 一种抑制酸牛乳乳清析出的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
US5856149A (en) 1995-06-01 1999-01-05 Wisconsin Alumni Research Foundation Method of producing conjugated fatty acids
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US20040121042A1 (en) * 2001-04-25 2004-06-24 Kabushiki Kaisha Yakult Honsha Fermented foods and process for producing the same
EP1264893A1 (en) * 2001-06-08 2002-12-11 Teagasc Dairy Products Research Centre CLA biosynthesis by bifidobacteria
US7250226B2 (en) * 2001-08-31 2007-07-31 Nippon Hoso Kyokai Phosphorescent compound, a phosphorescent composition and an organic light-emitting device
ATE445707T1 (de) 2002-04-12 2009-10-15 Yakult Honsha Kk Verfahren zur herstellung konjugierter fettsäure und mit diesem verfahren produzierte lebensmittel/getränke
JP4108613B2 (ja) * 2002-04-12 2008-06-25 チェビジェン・インコーポレイテッド 共役リノール酸を生産する新規の菌主、これを含有するカプセル剤及びその製造方法
KR100470460B1 (ko) * 2003-01-09 2005-02-05 대한민국 씨엘에이를 생산하는 락토바실러스 퍼멘텀 및 이를 이용한다량의 씨엘에이를 함유하는 배양액 제조방법

Also Published As

Publication number Publication date
EP1791946A1 (en) 2007-06-06
CN101044234A (zh) 2007-09-26
KR20060021240A (ko) 2006-03-07
KR100686558B1 (ko) 2007-02-23
JP2008511312A (ja) 2008-04-17
US20080057044A1 (en) 2008-03-06
WO2006025643A1 (en) 2006-03-09
MX2007002528A (es) 2007-07-04
EP1791946A4 (en) 2008-01-09
CA2579022C (en) 2012-09-11
CA2579022A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
BRPI0515618A (pt) cepa de lactobacillus plantarum, composição para produzir cla, processo para produção em massa de cla alimento funcional redutor de corpos de gordura, produtos diários, alimentos fermentados, medicamento para prevenção e tratamento de doenças relacionadas com a obesidade
BRPI0515227A (pt) cepa de lactobacillus rhamnosus, composição para produzir cla, processo para produção em massa de cla, alimento funcional com redução de corpo de gordura, produtos diários, alimentos fermentados e medicamento para prevenção e para tratamento de doenças relacionadas á obesidade
PH12013501877A1 (en) Nutritional compositions including branched chain fatty acids and methods of using same
PH12018500566B1 (en) Novel lactobacillus having various functions, and use thereof
MX2009005313A (es) Uso de productos de proteina vegetal estructurada para producir productos carnicos emulsionados.
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
WO2009050506A3 (en) Combination 059
CN107405369A8 (zh) 包含细菌的组合物及将其用于治疗和/或预防胃肠道疾病、代谢疾病和/或其它疾病的方法
HK1208993A1 (en) Obesity animal model and methods for making and using thereof
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
BRPI0412210A (pt) produto de gordura trans reduzida
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
MX2009003202A (es) Tratamiento de jugos, extractos y pigmentos de plantas.
BR112015015389A2 (pt) processamento do gênero musa e espécies relacionadas
EP1920774A4 (en) COMPOSITION WITH FUCOIDAN OR FUCOIDAN HYDROLYSATE AND IMMUNO-POTENTRIC MATERIAL
MY148893A (en) Combination of an hdac inhibitor and an antimetabolite
ATE509532T1 (de) Essbare prdoukte
WO2006105284A3 (en) Yeast fermentation of rice bran extracts
WO2008074935A3 (fr) Compositions biologiquement actives, procédé pour leur obtention, et applications biologiques
MX357919B (es) Composición farmacéutica para el tratamiento de la hipercolesterolemia.
WO2005005481A3 (en) Combination therapy for gastroenteric diseases caused by microorganisms
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
AU2003271807A8 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
MXPA06002648A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades medidas por cox-2.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PL BIO CO., LTD (KR) , CJ CHEILJEDANG CORP. (KR)

Free format text: TRANSFERIDO DE: CJ CORP.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C12N 1/20 , A23L 1/054 , A61K 35/66

Ipc: C12N 1/20 (2006.01), A23L 33/135 (2016.01), A61K 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]